Since two groundbreaking treatments were approved in late 2023, only a handful of patients have been able to access the ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Here’s what you can do to help boost your brain’s neurogenesis.

Shares of CRISPR Therapeutics CRSP have lost more than 30% in the past year. Though the stock soared at the onset of 2024, ...

If we assume all patients who began treatment with Casgevy last year progress to the administration stage, CRISPR and Vertex ...

ioTracker Cells, the new range within bit.bio's ioCells portfolio, deliver added visualisation capabilities that enhance the portfolio of deterministically-programmed human iPSC-derived cells powered ...

Ongoing launch of CASGEVY® continues to gain momentum--2025 is poised to be a catalyst-rich year with key updates across several ...

PRNewswire Bengaluru Karnataka [India] January 16 Bengaluru-based biotechnology startup CrisprBits Private Limited has ...

Analysis of CRISPR/Cas9 edited cells are done to check the efficacy of the system in introducing mutations (indels, deletions, substitutions or mismatches) in the DNA sequences of the edited cell ...

New facility to support advancements in molecular diagnostics, rare disease research, and industrial microbiology ...